SILO
Income statement / Annual
Last year (2024), Silo Pharma, Inc.'s total revenue was $72,102.00,
a decrease of 0.00% from the previous year.
In 2024, Silo Pharma, Inc.'s net income was -$4.39 M.
See Silo Pharma, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Operating Revenue |
$72,102.00 |
$72,102.00 |
$72,102.00 |
$71,264.00 |
$40,923.00 |
$40,569.00 |
$0.00 |
$847,407.00 |
-$669,480.00 |
-$145,185.00 |
Cost of Revenue |
$5,838.00
|
$5,838.00
|
$5,838.00
|
$5,004.00
|
$176,126.00
|
$27,387.00
|
$17,550.00
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit |
$66,264.00
|
$66,264.00
|
$66,264.00
|
$66,260.00
|
-$135,203.00
|
$13,182.00
|
-$17,550.00
|
$847,407.00
|
-$669,480.00
|
-$145,185.00
|
Gross Profit Ratio |
0.92
|
0.92
|
0.92
|
0.93
|
-3.3
|
0.32
|
0
|
1
|
1
|
1
|
Research and Development Expenses |
$2.37 M
|
$845,092.00
|
$1.29 M
|
$693,910.00
|
$88,800.00
|
$63,465.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative Expenses |
$1.20 M
|
$3.08 M
|
$2.43 M
|
$2.27 M
|
$2.18 M
|
$864,180.00
|
$459,830.00
|
$313,371.00
|
$300,994.00
|
$167,700.00
|
Selling & Marketing Expenses |
-$900,461.00
|
$0.00
|
-$1.27 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$298,284.00
|
$3.08 M
|
$2.43 M
|
$2.27 M
|
$2.18 M
|
$864,180.00
|
$459,830.00
|
$313,371.00
|
$300,994.00
|
$167,700.00
|
Other Expenses |
$2.11 M
|
$0.00
|
$2.17 M
|
$1.95 M
|
$3,000.00
|
$765,720.00
|
$314,607.00
|
$177,500.00
|
$142,500.00
|
$96,613.00
|
Operating Expenses |
$4.77 M
|
$3.92 M
|
$3.71 M
|
$2.96 M
|
$2.27 M
|
$927,645.00
|
$459,830.00
|
$490,871.00
|
$443,494.00
|
$264,313.00
|
Cost And Expenses |
$4.78 M
|
$3.93 M
|
$3.72 M
|
$2.96 M
|
$2.45 M
|
$955,032.00
|
$459,830.00
|
$427,961.00
|
$443,494.00
|
$264,313.00
|
Interest Income |
$333,165.00
|
$398,530.00
|
$72,637.00
|
$1,210.00
|
$11,543.00
|
$12,196.00
|
$4,218.00
|
$20,483.00
|
$49,836.00
|
$40,341.00
|
Interest Expense |
$5,084.00
|
$4,869.00
|
$2,199.00
|
$3,036.00
|
$269,267.00
|
$62,928.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$6,185.00
|
$229,378.00
|
$72,637.00
|
-$147,290.00
|
$179,919.00
|
$28,136.00
|
$17,550.00
|
-$701,104.00
|
$719,316.00
|
$192,326.00
|
EBITDA |
-$4.38 M |
-$3.63 M |
-$3.91 M |
$4.19 M |
-$2.39 M |
-$930,403.00 |
-$951,914.00 |
$0.00 |
$0.00 |
-$217,172.00 |
EBITDA Ratio |
-60.77
|
-50.29
|
-54.16
|
58.73
|
-58.48
|
-22.93
|
0
|
0
|
0
|
1.5
|
Operating Income Ratio |
-65.26
|
-53.47
|
-50.59
|
-38.51
|
-62.87
|
-22.93
|
0
|
-0.56
|
0.59
|
1.5
|
Total Other Income/Expenses Net |
$312,814.00
|
$224,509.00
|
-$279,732.00
|
$6.93 M
|
-$464,550.00
|
-$82,891.00
|
-$375,221.00
|
$826,924.00
|
-$719,316.00
|
-$192,326.00
|
Income Before Tax |
-$4.39 M
|
-$3.63 M
|
-$3.91 M
|
$4.18 M
|
-$3.04 M
|
-$1.01 M
|
-$969,463.00
|
$356,536.00
|
-$1.11 M
|
-$409,498.00
|
Income Before Tax Ratio |
-60.93
|
-50.36
|
-54.19
|
58.68
|
-74.23
|
-24.98
|
0
|
0.42
|
1.66
|
2.82
|
Income Tax Expense |
$0.00
|
$0.00
|
$1,163.00
|
$24,876.00
|
$92,348.00
|
$34,792.00
|
-$513,851.00
|
-$62,910.00
|
$696,500.00
|
$0.00
|
Net Income |
-$4.39 M
|
-$3.70 M
|
-$3.91 M
|
$3.90 M
|
-$3.13 M
|
-$1.05 M
|
-$969,463.00
|
$356,536.00
|
-$1.11 M
|
-$409,498.00
|
Net Income Ratio |
-60.93
|
-51.33
|
-54.21
|
54.78
|
-76.48
|
-25.83
|
0
|
0.42
|
1.66
|
2.82
|
EPS |
-1.19 |
-1.2 |
-1.71 |
2.06 |
-2.37 |
-1.24 |
-0.99 |
0.5 |
-1.11 |
-0.4 |
EPS Diluted |
-1.19 |
-1.2 |
-1.71 |
2.03 |
-2.37 |
-1.24 |
-0.99 |
0.5 |
-1.11 |
-0.4 |
Weighted Average Shares Out |
$3.68 M
|
$3.08 M
|
$2.28 M
|
$1.90 M
|
$1.32 M
|
$842,295.00
|
$982,028.00
|
$1.00 M
|
$1.00 M
|
$1.01 M
|
Weighted Average Shares Out Diluted |
$3.68 M
|
$3.08 M
|
$2.28 M
|
$1.92 M
|
$1.32 M
|
$842,295.00
|
$982,028.00
|
$1.04 M
|
$1.00 M
|
$1.01 M
|
Link |
|
|
|
|
|
|
|
|
|
|